Home Neuronal Signaling Adrenergic Receptor antagonist Timolol Maleate For research use only.

Timolol Maleate

Synonyms: MK-950,(S)-Timolol Maleate

Timolol Maleate (MK-950,(S)-Timolol Maleate) is a non-selective, beta-adrenergic receptor antagonist for β1/β2 with Ki of 1.97 nM/2.0 nM.

Timolol Maleate Chemical Structure

Timolol Maleate Chemical Structure

CAS: 26921-17-5

Selleck's Timolol Maleate has been cited by 1 publication

Purity & Quality Control

Batch: Purity: 99.97%
99.97

Other Adrenergic Receptor Products

Related compound libraries

Choose Selective Adrenergic Receptor Inhibitors

Biological Activity

Description Timolol Maleate (MK-950,(S)-Timolol Maleate) is a non-selective, beta-adrenergic receptor antagonist for β1/β2 with Ki of 1.97 nM/2.0 nM.
Targets
β1-adrenergic receptor [2] β2-adrenergic receptor [2]
1.97 nM(Ki) 2.0 nM(Ki)
In vitro
In vitro

Timolol Maleate is a beta-adrenergic antagonist similar in action to propranolol. The levo-isomer is the more active. Timolol has been proposed as an antihypertensive, antiarrhythmic, antiangina, and antiglaucoma agent. Similar to propranolol and nadolol, timolol is a non-selective, beta-adrenergic receptor antagonist. [1] Timolol has a higher affinity for the beta 2-adrenoceptor than for the beta 1-adrenoceptor in human atrium. Timolol does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane-stabilizing) activity, but does possess a relatively high degree of lipid solubility. [3] Timolol, when applied topically to the eye, has the action of reducing elevated, as well as normal, intraocular pressure, whether or not accompanied by glaucoma. Elevated intraocular pressure is a major risk factor in the pathogenesis of glaucomatous visual field loss and optic nerve damage. [4] Like propranolol and nadolol, timolol competes with adrenergic neurotransmitters such as catecholamines for binding at β1-adrenergic receptors in the heart and vascular smooth muscle and β2-receptors in the bronchial and vascular smooth muscle. β1-receptor blockade results in a decrease in resting and exercise heart rate and cardiac output, a decrease in both systolic and diastolic blood pressure, and, possibly, a reduction in reflex orthostatic hypotension. β2-blockade results in an increase in peripheral vascular resistance. The exact mechanism whereby timolol reduces ocular pressure is still not known. The most likely action is by decreasing the secretion of aqueous humor. [2]
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04828057 Completed Ocular Surface Disease|Primary Open Angle Glaucoma Santen Pharmaceutical (Taiwan) Co. LTD September 1 2021 --
NCT03282981 Active not recruiting Chronic Diabetic Foot Ulcers|Diabetic Neuropathic Ulcers|Non Healing Wound VA Office of Research and Development|VA Northern California Health Care System June 14 2018 Phase 3
NCT04903366 Completed Glaucoma Open-Angle|Chronic Wounds VA Northern California Health Care System November 21 2017 --

Chemical lnformation & Solubility

Molecular Weight 432.49 Formula

C13H24N4O3S.C4H4O4
CAS No. 26921-17-5 SDF Download Timolol Maleate SDF
Smiles CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 86 mg/mL ( (198.84 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 86 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Timolol Maleate | Timolol Maleate ic50 | Timolol Maleate price | Timolol Maleate cost | Timolol Maleate solubility dmso | Timolol Maleate purchase | Timolol Maleate manufacturer | Timolol Maleate research buy | Timolol Maleate order | Timolol Maleate mouse | Timolol Maleate chemical structure | Timolol Maleate mw | Timolol Maleate molecular weight | Timolol Maleate datasheet | Timolol Maleate supplier | Timolol Maleate in vitro | Timolol Maleate cell line | Timolol Maleate concentration | Timolol Maleate nmr